327 related articles for article (PubMed ID: 11594706)
1. From Burkitt's lymphoma to chronic active Epstein-Barr virus (EBV) infection: an expanding spectrum of EBV-associated diseases.
Okano M; Gross TG
Pediatr Hematol Oncol; 2001; 18(7):427-42. PubMed ID: 11594706
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-associated lymphoproliferative disorders.
Rezk SA; Weiss LM
Hum Pathol; 2007 Sep; 38(9):1293-304. PubMed ID: 17707260
[TBL] [Abstract][Full Text] [Related]
3. Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases.
Cohen JI
Semin Hematol; 2003 Apr; 40(2):116-23. PubMed ID: 12704588
[TBL] [Abstract][Full Text] [Related]
4. Haematological associations of Epstein-Barr virus infection.
Okano M
Baillieres Best Pract Res Clin Haematol; 2000 Jun; 13(2):199-214. PubMed ID: 10942621
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-associated lymphomas.
Gandhi MK
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):77-89. PubMed ID: 16441211
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus--associated diseases in humans.
Kawa K
Int J Hematol; 2000 Feb; 71(2):108-17. PubMed ID: 10745621
[TBL] [Abstract][Full Text] [Related]
7. Infection with Epstein-Barr virus and cancer: an epidemiological review.
Serraino D; Piselli P; Angeletti Cl; Scuderi M; Ippolito G; Capobianchi MR
J Biol Regul Homeost Agents; 2005; 19(1-2):63-70. PubMed ID: 16178276
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases.
Yachie A; Kanegane H; Kasahara Y
Semin Hematol; 2003 Apr; 40(2):124-32. PubMed ID: 12704589
[TBL] [Abstract][Full Text] [Related]
9. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
[TBL] [Abstract][Full Text] [Related]
10. Endemic Burkitt's lymphoma as a polymicrobial disease: new insights on the interaction between Plasmodium falciparum and Epstein-Barr virus.
Chene A; Donati D; Orem J; Mbidde ER; Kironde F; Wahlgren M; Bejarano MT
Semin Cancer Biol; 2009 Dec; 19(6):411-20. PubMed ID: 19897039
[TBL] [Abstract][Full Text] [Related]
11. The contribution of the Epstein-Barr virus to the pathogenesis of childhood lymphomas.
Cader FZ; Kearns P; Young L; Murray P; Vockerodt M
Cancer Treat Rev; 2010 Jun; 36(4):348-53. PubMed ID: 20193983
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease.
Berger C; Day P; Meier G; Zingg W; Bossart W; Nadal D
J Med Virol; 2001 Aug; 64(4):505-12. PubMed ID: 11468736
[TBL] [Abstract][Full Text] [Related]
13. Reflections on Epstein-Barr virus: some recently resolved old uncertainties.
Epstein MA
J Infect; 2001 Aug; 43(2):111-5. PubMed ID: 11676516
[TBL] [Abstract][Full Text] [Related]
14. Burkitt's lymphoma following a pediatric liver transplantation: predictive negative value of serologic response to Epstein-Barr virus.
Yilmaz A; Hazar V; Akçam M; Inanç-Gürer E; Ceken K; Artan R
Turk J Pediatr; 2007; 49(4):434-6. PubMed ID: 18246749
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma.
Shah KM; Young LS
Clin Microbiol Infect; 2009 Nov; 15(11):982-8. PubMed ID: 19874382
[TBL] [Abstract][Full Text] [Related]
18. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
[TBL] [Abstract][Full Text] [Related]
19. [Epstein-Barr virus infection--a lympho- and epitheliotropic infection].
Näher H; Petzoldt D
Hautarzt; 1992 Mar; 43(3):114-9. PubMed ID: 1315723
[TBL] [Abstract][Full Text] [Related]
20. Clinical and demographic characteristics of Epstein-Barr virus-associated childhood Burkitt's lymphoma in Southeastern Brazil: epidemiological insights from an intermediate risk region.
Hassan R; Klumb CE; Felisbino FE; Guiretti DM; White LR; Stefanoff CG; Barros MH; Seuánez HN; Zalcberg IR
Haematologica; 2008 May; 93(5):780-3. PubMed ID: 18367488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
